Safety and Effectiveness of Aflibercept + Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) for the Treatment of Patients with Metastatic Colorectal Cancer (mCRC) in Current Clinical Practice: OZONE Study.
Saved in:
| Title: | Safety and Effectiveness of Aflibercept + Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) for the Treatment of Patients with Metastatic Colorectal Cancer (mCRC) in Current Clinical Practice: OZONE Study. |
|---|---|
| Authors: | Chau, Ian1 (AUTHOR) Ian.Chau@rmh.nhs.uk, Fakih, Marwan2 (AUTHOR) mfakih@coh.org, García-Alfonso, Pilar3 (AUTHOR) pgarcaalfonso@gmail.com, Linke, Zdenĕk4 (AUTHOR) Zdenek.Linke@fnmotol.cz, Ruiz Casado, Ana5 (AUTHOR) anaruizcasado@gmail.com, Marques, Eduardo Polo6 (AUTHOR) eduardopolomarques@hotmail.com, Picard, Pascaline7 (AUTHOR) Pascaline.Picard-ext@sanofi.com, Celanovic, Marina8 (AUTHOR) marina.celanovic@sanofi.com, Cartwright, Thomas9 (AUTHOR) tcartwright4@cox.net |
| Source: | Cancers. Mar2020, Vol. 12 Issue 3, p657. 1p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
